Abstract
Telogen effluvium represents one of the most common causes of hair loss. The treatment of telogen effluvium primarily relies on treating the underlying cause if it can be identified. Nutritional supplements are often prescribed even when there are no associated vitamin or oligoelement deficiencies. Education, reassurance, and shampooing are also very important steps.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–5. http://www.ncbi.nlm.nih.gov/pubmed/12190639. Accessed 8 Oct 2018.
Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):591–603. https://doi.org/10.4103/0378-6323.116731.
Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: common and uncommon cases. Int J Dermatol. 2007;46(s1):18–22. https://doi.org/10.1111/j.1365-4632.2007.03457.x.
Al-Refu K. Hair loss in children: common and uncommon causes; clinical and epidemiological study in Jordan. Int J Trichology. 2013;5(4):185. https://doi.org/10.4103/0974-7753.130393.
Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. 1996;35(6):899–906. http://www.ncbi.nlm.nih.gov/pubmed/8959948. Accessed 8 Oct 2018.
Trüeb RM. Telogen effluvium: is there a need for a new classification? Ski Appendage Disord. 2016;2(1–2):39–44. https://doi.org/10.1159/000446119.
Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993;129(3):356–63. http://www.ncbi.nlm.nih.gov/pubmed/8447677. Accessed 8 Oct 2018.
Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–3. https://doi.org/10.7860/JCDR/2015/15219.6492.
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404. http://www.ncbi.nlm.nih.gov/pubmed/12190640. Accessed 8 Oct 2018.
Goette DK, Odom RB. Alopecia in crash dieters. JAMA. 1976;235(24):2622–3. http://www.ncbi.nlm.nih.gov/pubmed/946869. Accessed 9 Oct 2018.
Yavuz IH, Yavuz GO, Bilgili SG, Demir H, Demir C. Assessment of heavy metal and trace element levels in patients with telogen effluvium. Indian J Dermatol. 2018;63(3):246–50. https://doi.org/10.4103/ijd.IJD_610_17.
Sinclair R. Diffuse hair loss. Int J Dermatol. 1999;38 Suppl 1:8–18. http://www.ncbi.nlm.nih.gov/pubmed/10369535. Accessed 9 Oct 2018
Sperling LC, Sinclair RD, El Shabrawi-Caelen L. Dermatology 4th Edition Chapter 69. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Philadelphia: Elsevier; 2017. p. 1168–71.
Loh S-H, Lew B-L, Sim W-Y. Localized telogen effluvium following hair transplantation. Ann Dermatol. 2018;30(2):214–7. https://doi.org/10.5021/ad.2018.30.2.214.
Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol. 2001;137(2):187–90. http://www.ncbi.nlm.nih.gov/pubmed/11176691. Accessed 10 Oct 2018.
Kim J-H, Lew B-L, Sim W-Y. Localized telogen effluvium after face lift surgery. Ann Dermatol. 2015;27(1):119–20. https://doi.org/10.5021/ad.2015.27.1.119.
Cassano N, Amerio P, D’Ovidio R, Vena GA. Hair disorders associated with autoimmune connective tissue diseases. G Ital Dermatol Venereol. 2014;149(5):555–65. http://www.ncbi.nlm.nih.gov/pubmed/24975949. Accessed 10 Oct 2018.
Bergfeld WF, Mulinari-Brenner F. Shedding: how to manage a common cause of hair loss. Cleve Clin J Med. 2001;68(3):256–61. http://www.ncbi.nlm.nih.gov/pubmed/11263854. Accessed 8 Oct 2018.
Trüeb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284–97, 284–298. https://doi.org/10.1111/j.1610-0387.2010.07261.x.
Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29(4):568–75. http://www.ncbi.nlm.nih.gov/pubmed/8408792. Accessed 9 Oct 2018.
Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996;14(4):723–31. http://www.ncbi.nlm.nih.gov/pubmed/9238330. Accessed 9 Oct 2018.
Chen W, Yang C-C, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol. 2010;20(2):145–51. https://doi.org/10.1684/ejd.2010.0828.
Rebora A. Intermittent chronic telogen effluvium. Ski Appendage Disord. 2017;3(1):36–8. https://doi.org/10.1159/000455882.
Sinclair R. Chronic telogen effluvium: a study of 5 patients over 7 years. J Am Acad Dermatol. 2005;52(2 Suppl 1):12–6. https://doi.org/10.1016/j.jaad.2004.05.040.
McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017;76(3):472–7. https://doi.org/10.1016/J.JAAD.2016.10.002.
Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents. Front Med. 2017;4:112. https://doi.org/10.3389/fmed.2017.00112.
Martínez-Velasco MA, Vázquez-Herrera NE, Maddy AJ, Asz-Sigall D, Tosti A. The hair shedding visual scale: a quick tool to assess hair loss in women. Dermatol Ther (Heidelb). 2017;7(1):155–65. https://doi.org/10.1007/s13555-017-0171-8.
Sinclair R. Hair shedding in women: how much is too much? Br J Dermatol. 2015;173(3):846–8. https://doi.org/10.1111/bjd.13873.
Kivanç-Altunay I, Savaş C, Gökdemir G, Köşlü A, Ayaydin EB. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol. 2003;42(9):691–3. http://www.ncbi.nlm.nih.gov/pubmed/12956679. Accessed 10 Oct 2018.
Bergfeld W. Telogen effluvium. In: Hordinsky M, Ofori AO, editors. UpToDate. Waltham, MA: UpToDate. Accessed on 13 Oct 2018.
Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040–8. https://doi.org/10.1016/j.jaad.2012.02.013.
Harth W, Hermes B, Niemeier V, Gieler U. Clinical pictures and classification of somatoform disorders in dermatology. Eur J Dermatol. 2006;16(6):607–14. http://www.ncbi.nlm.nih.gov/pubmed/17229599. Accessed 9 Oct 2018.
Valdés F. Vitamin C. Actas Dermosifiliogr. 2006;97(9):557–68. http://www.ncbi.nlm.nih.gov/pubmed/17173758. Accessed 25 Nov 2018.
Sant’Anna Addor FA, Donato LC, Melo CSA. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. Clin Cosmet Investig Dermatol. 2018;11:431–6. https://doi.org/10.2147/CCID.S173082.
Ablon G. A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair. Dermatol Res Pract. 2015;2015:841570. https://doi.org/10.1155/2015/841570.
Viviscal. Viviscal extra strength. https://www.viviscal.com/advanced-hair-health-supplements/. Accessed 21 Nov 2018.
Ablon G, Kogan S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair. J Drugs Dermatol. 2018;17(5):558–65. http://www.ncbi.nlm.nih.gov/pubmed/29742189. Accessed 21 Nov 2018.
Bergner T. Diffuse effluvium, damage to hair structure, and disturbances of nail growth treated successfully. Dt Derm. 1999;47:881–4. http://www.assospharma.com/pdf/panplus/Bergner1999.pdf. Accessed 21 Nov 2018.
Le Floc’h C, Cheniti A, Connétable S, Piccardi N, Vincenzi C, Tosti A. Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol. 2015;14(1):76–82. https://doi.org/10.1111/jocd.12127.
Nichols AJ, Hughes OB, Canazza A, Zaiac MN. An open-label evaluator blinded study of the efficacy and safety of a new nutritional supplement in androgenetic alopecia: a pilot study. J Clin Aesthet Dermatol. 2017;10(2):52–6. http://www.ncbi.nlm.nih.gov/pubmed/28367262. Accessed 12 Jan 2019.
Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004;123(3):455–7. https://doi.org/10.1111/j.0022-202X.2004.23237.x.
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186–94. http://www.ncbi.nlm.nih.gov/pubmed/14996087. Accessed 13 Oct 2018.
The Transfer of Drugs and Other Chemicals Into Human Milk. http://pediatrics.aappublications.org/content/108/3/776.full.html located on the World Wide Web at: AMERICAN ACADEMY OF PEDIATRICS The Transfer of Drugs and Other Chemicals Into Human Milk. 2001. http://pediatrics.aappublications.org/content/108/3/776.full.html. Accessed 25 Nov 2018.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(Suppl 6):S1–57. https://doi.org/10.1111/j.1610-0379.2011.07802.x.
Garg S, Manchanda S. Platelet-rich plasma-an “Elixir” for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4:64. https://doi.org/10.21037/sci.2017.06.07.
Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–27. https://doi.org/10.1007/s40257-013-0060-6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Burroway, B., Griggs, J., Martinez-Velasco, M.A., Tosti, A. (2020). Telogen Effluvium. In: Tosti, A., Asz-Sigall, D., Pirmez, R. (eds) Hair and Scalp Treatments. Springer, Cham. https://doi.org/10.1007/978-3-030-21555-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-21555-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21554-5
Online ISBN: 978-3-030-21555-2
eBook Packages: MedicineMedicine (R0)